Assessing Metabolic State of 3D Tumor Models
PROTEIN FLUIDICS
10/20/21, 11:00 AM
America/Los_Angeles (PT) -7
Description
Translational cancer research is increasingly incorporating 3D cell models like organoids, tumoroids and other patient-derived samples. Progression of a tumor and its response to therapy has been closely linked to metabolic reprogramming in cancer cells. Therefore, metabolism assays have become an important part of the tumor treatment response multifunctional profiling. This necessitates efficient workflows for timed supernatant sample collection to analyze the dynamics of metabolite secretion in response to treatment.
In this joint webinar by Protein Fluidics and Promega, scientists will show how 3D-optimized metabolite assays can be used with cell models to assess their metabolic state. An automated Pu·MA System workflow to capture dynamic metabolite secretion from patient-derived tumoroids will be featured.
The speakers will also discuss technical aspects of assay optimization, including monitoring changes in metabolites upon timed drug treatments.
Previous registration necessary?
NO
YES
Simultaneous translation ?
NO
YES
Will it be recorded?
NO
YES
Luminescence Approaches for Monitoring Cellular Energy Metabolism, Multifunctional Profiling & Metabolite Assays using Patient-Derived Tumoroids
Inglês
Speakers
Jolanta Vidugiriene, Katya Nikolov
Link to the Event
Banner to the Event
Register your event here
Already have an account? LOGIN HERE. If You don't have an account you need to create a free account.